Announcement of the signing of a Non-Binding Letter of Intent for OBI Pharma, Inc., to issue new shares to AbProtix, Inc., in exchange for up to 70% stake in AP Biosciences

DATE OF THE EVENT: 30 December 2016 COUNTERPARTY TO THE CONTRACT OR COMMITMENT: AbProtix Inc., a company registered in the Cayman Islands. RELATIONSHIP TO THE COMPANY: None STARTING AND ENDING DATES (OR RESCISSION DATE) OF THE CONTRACT OR COMMITMENT: The Letter of Intent (LOI) becomes invalid automatically when the new OBI shares are issued and […]